Page URL:

Prostate cancer blood test that 'reads genetic changes like a barcode' trialled successfully

15 July 2013
Appeared in BioNews 677

Scientists have developed a 'barcode' blood test that reads genetic changes to pick out the most aggressive prostate cancers.

'We've shown it is possible to learn more about prostate cancers by the signs they leave in the blood, allowing us to develop a test that is potentially more accurate than those available now and easier for patients than taking a biopsy', said Professor Johann de Bono, who led the study at the Institute of Cancer Research, UK.

The test works by reading the pattern of genes switched on and off in blood cells as a result of the disease. 'Our test reads the pattern of genetic activity like a barcode, picking up signs that a patient is likely to have a more aggressive cancer. Doctors should then be able to adjust the treatment they give accordingly', said Professor de Bono.

Researchers scanned all the genes present in blood samples from 100 patients with either advanced or low-risk, early-stage prostate cancer. The patients were divided into four groups based on their pattern of gene activity, as measured by RNA levels. Patients in one of the four groups showed a significantly lower survival rate after two and a half years when compared to the others. These patients had genetic 'barcodes' that shared activity in nine specific genes.

Some of the nine genes were involved in the immune system, leading scientists to speculate that patients with this genetic profile had defects in their immune systems that allowed the cancer to spread more aggressively.

Using these nine genes, researchers were able to identify patients who had the worst survival rates in a separate group of 70 patients with advanced cancer. Those without the genetic pattern survived more than twice as long as those with the genetic pattern.

Similar findings were also published by US researchers, led by Professor William Oh at the Tisch Cancer Institute at the Mount Sinai Medical Center, USA. This blood test used six genes to identify patients with more aggressive prostate cancer.

'For years it has been extremely difficult to try to predict which men have very aggressive tumours and which do not', said Dr Kate Holmes, head of research at Prostate Cancer UK that part-funded the study, to the Mail Online.

Dr Holmes added: 'If these early findings can be confirmed by much larger studies over time this method could potentially be used to help inform how aggressive a tumour will be and empower men and their clinicians to make much more informed decisions about which treatments are best for their individual circumstances'.

The studies were published in the journal Lancet Oncology.

14 September 2015 - by Isobel Steer 
A US startup called Pathway Genomics has launched the first commercial 'liquid biopsy' to identify cancerous mutations via a blood test...
1 September 2015 - by Dr Hannah Somers 
Scientists have developed a blood test that can predict several months in advance which breast cancer patients will relapse.
3 August 2015 - by Kirsty Oswald 
Researchers have found that prostate cancer can be divided into five subgroups with distinct genetic fingerprints...
22 September 2014 - by James Brooks 
A study where the tumour DNA of 16 prostate cancer patients was frequently checked suggests that, in some patients, commonly used anti-cancer drugs may actually boost tumour growth after a while...
15 September 2014 - by Dr Anna Cauldwell 
Twenty-three genetic variants associated with increased risk of prostate cancer have been identified in a new study, bringing the total number of susceptibility variants for the disease to 100...
15 May 2012 - by Sarah Pritchard 
A DNA test for men with prostate cancer could indicate whether their cancer is likely to recur after treatment, and if so, how aggressively, say researchers from the University of Pittsburg School of Medicine, USA...
8 May 2012 - by Dr Kimberley Bryon-Dodd 
A link between modifications to a white blood cell gene and an increased risk of breast cancer could be the basis for a simple blood test to identify women most at risk of developing the disease...
26 March 2012 - by Sarah Pritchard 
A genetic test could be used to spare breast cancer patients from having to undergo postoperative chemotherapy...
16 January 2012 - by Dr Linda Wijlaars 
A rare gene variant that could increase the risk of prostate cancer has been identified by researchers in the USA. Although the variant accounts for only a small fraction of all prostate cancers, the study found it was more common in men with an inherited form of the cancer and in those who are diagnosed before the age of 55...
14 February 2011 - by Victoria Kay 
A genetic screening test could help doctors to identify men with the most aggressive types of prostate cancer, UK scientists believe. The test could save men with milder forms of the disease from unnecessary surgery and its potentially serious side effects...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.